Xeris Pharmaceuticals Stock Forecast - Triple Exponential Smoothing
| XERS Stock | USD 3.09 0.05 1.64% |
The Triple Exponential Smoothing forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 3.11 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 3.84. Xeris Stock Forecast is based on your current time horizon.
Xeris |
Xeris Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 26th of November
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 3.11 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.84.Please note that although there have been many attempts to predict Xeris Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Xeris Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Xeris Pharmaceuticals Stock Forecast Pattern
| Backtest Xeris Pharmaceuticals | Xeris Pharmaceuticals Price Prediction | Buy or Sell Advice |
Xeris Pharmaceuticals Forecasted Value
In the context of forecasting Xeris Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Xeris Pharmaceuticals' downside and upside margins for the forecasting period are 0.47 and 5.76, respectively. We have considered Xeris Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Xeris Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Xeris Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0098 |
| MAD | Mean absolute deviation | 0.0651 |
| MAPE | Mean absolute percentage error | 0.0222 |
| SAE | Sum of the absolute errors | 3.8429 |
Predictive Modules for Xeris Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xeris Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Xeris Pharmaceuticals
For every potential investor in Xeris, whether a beginner or expert, Xeris Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Xeris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Xeris. Basic forecasting techniques help filter out the noise by identifying Xeris Pharmaceuticals' price trends.View Xeris Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Xeris Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Xeris Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Xeris Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Xeris Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Xeris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xeris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xeris Pharmaceuticals stock market strength indicators, traders can identify Xeris Pharmaceuticals entry and exit signals to maximize returns.
Xeris Pharmaceuticals Risk Indicators
The analysis of Xeris Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Xeris Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xeris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.86 | |||
| Semi Deviation | 2.65 | |||
| Standard Deviation | 2.64 | |||
| Variance | 6.98 | |||
| Downside Variance | 10.47 | |||
| Semi Variance | 7.05 | |||
| Expected Short fall | (2.07) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xeris Stock Analysis
When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.